scholarly journals Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

2016 ◽  
Vol 17 (7) ◽  
pp. 976-983 ◽  
Author(s):  
Sarah B Goldberg ◽  
Scott N Gettinger ◽  
Amit Mahajan ◽  
Anne C Chiang ◽  
Roy S Herbst ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Early Analysis ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

2017 ◽  
Vol 18 (10) ◽  
pp. 1307-1316 ◽  
Author(s):  
David Planchard ◽  
Egbert F Smit ◽  
Harry J M Groen ◽  
Julien Mazieres ◽  
Benjamin Besse ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

2016 ◽  
Vol 17 (5) ◽  
pp. 642-650 ◽  
Author(s):  
David Planchard ◽  
Tae Min Kim ◽  
Julien Mazieres ◽  
Elisabeth Quoix ◽  
Gregory Riely ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

2020 ◽  
Vol 21 (6) ◽  
pp. 786-795 ◽  
Author(s):  
Catherine A Shu ◽  
Justin F Gainor ◽  
Mark M Awad ◽  
Codruta Chiuzan ◽  
Claud M Grigg ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 2 Trial

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

2021 ◽  
Vol 22 (3) ◽  
pp. 321-331 ◽  
Author(s):  
Bjørn Henning Grønberg ◽  
Kristin Toftaker Killingberg ◽  
Øystein Fløtten ◽  
Odd Terje Brustugun ◽  
Kjersti Hornslien ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Standard Dose ◽  
Small Cell ◽  
High Dose ◽  
Phase 2 ◽  
Thoracic Radiotherapy ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document